Apparatuses and methods for renal neuromodulation

US9072527B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9072527-B2
Application numberUS-201313942223-A
CountryUS
Kind codeB2
Filing dateJul 15, 2013
Priority dateApr 8, 2002
Publication dateJul 7, 2015
Grant dateJul 7, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for extravascular delivery of pulsed electric fields to achieve such neuromodulation.

First claim

Opening claim text (preview).

We claim: 1. A method for renal neuromodulation, the method comprising: extravascularly positioning a distal tip of a probe in an annular space between renal fascia and renal vasculature of a human patient and in proximity to renal nerves along the renal vasculature of the patient; delivering a catheter through the probe to a treatment location proximate the renal nerves, wherein the catheter comprises an anchoring mechanism having— a first collar; a second collar located distally relative to the first collar; an expandable member connected to the first and second collars, wherein the expandable member is transformable between a collapsed configuration and an expanded configuration; and a plurality of electrodes at the expandable member; and delivering an electric field to the renal nerves via the electrodes to at least partially inhibit neural signaling along the renal nerves. 2. The method of claim 1 , further comprising monitoring a response of at least one physiological parameter of the patient to treatment of the renal nerves. 3. The method of claim 1 , further comprising infusing an agent via the catheter to create a working space to facilitate placement of the electrodes. 4. The method of claim 1 , further comprising infusing an agent via the catheter to enhance the neurodestructive or neuromodulatory effect of the applied electric field. 5. The method of claim 1 , further comprising removing the catheter and probe from the patient after therapy. 6. The method of claim 1 , wherein the expandable member is a braid, mesh or woven member. 7. The method of claim 1 , further comprising moving at least one of the first and second collars toward the other of the first and second collars to reduce the distance between the first and second collars. 8. The method of claim 1 , further comprising reducing a distance between the first collar and the second collar to expand the expandable member to the expanded configuration. 9. The method of claim 1 , wherein the electric field is a pulsed electric field. 10. The method of claim 1 , wherein the patient has clinical symptoms of hypertension and wherein the method reduces or alleviates the clinical symptoms of hypertension. 11. The method of claim 1 , wherein the patient has clinical symptoms of congestive heart failure and wherein the method reduces or alleviates the clinical symptoms of congestive heart failure. 12. The method of claim 1 , wherein the patient has clinical symptoms of renal disease and wherein the method reduces or alleviates the clinical symptoms of renal disease.

Assignees

Inventors

Classifications

  • Irreversible electroporation · CPC title

  • of urogenital or gastrointestinal organs, e.g. for incontinence control · CPC title

  • Power or energy · CPC title

  • alternating or intermittent currents {(applying electric fields by inductive or capacitive coupling A61N1/40; microwave apparatus A61N5/02)} · CPC title

  • Radiation therapy (ultrasound therapy A61N7/00; devices or apparatus applicable to both therapy and diagnosis A61B6/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9072527B2 cover?
Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be effic…
Who is the assignee on this patent?
Deem Mark, Zarins Denise, Sutton Douglas, and 5 more
What technology area does this patent fall under?
Primary CPC classification A61N1/0551. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).